Works matching IS 00099236 AND DT 2019 AND VI 106 AND IP 5
Results: 36
The Future of Precision Medicine.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 903, doi. 10.1002/cpt.1622
- By:
- Publication type:
- Article
In This Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 901, doi. 10.1002/cpt.1621
- Publication type:
- Article
ASCPT News.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 909, doi. 10.1002/cpt.1623
- Publication type:
- Article
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 907, doi. 10.1002/cpt.1620
- Publication type:
- Article
Preemptively Precise: Returning and Updating Pharmacogenetic Test Results to Realize the Benefits of Preemptive Testing.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 942, doi. 10.1002/cpt.1613
- By:
- Publication type:
- Article
Who Believes They Are "Just Average": Informing the Treatment of Individual Patients Using Population Data.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 939, doi. 10.1002/cpt.1612
- By:
- Publication type:
- Article
Precision Medicine: Lessons Learned From Implementation of a Pharmacogenetics‐Based Patient Care Program in a Real‐World Setting.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 933, doi. 10.1002/cpt.1611
- By:
- Publication type:
- Article
Genetic Predisposition to Anticonvulsant Hypersensitivity.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 919, doi. 10.1002/cpt.1610
- By:
- Publication type:
- Article
Achieving Mucosal Healing in Inflammatory Bowel Diseases: Which Drug Concentrations Need to Be Targeted?
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 945, doi. 10.1002/cpt.1609
- By:
- Publication type:
- Article
Managing Increased Accessibility to Pharmacogenomic Data.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 922, doi. 10.1002/cpt.1602
- By:
- Publication type:
- Article
Pharmacogenomics in Practice.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 936, doi. 10.1002/cpt.1600
- By:
- Publication type:
- Article
Concomitant Intake of Coca‐Cola to Manage the Drug–Drug Interaction Between Velpatasvir and Omeprazole Studied in Healthy Volunteers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 1093, doi. 10.1002/cpt.1569
- By:
- Publication type:
- Article
Racial/Ethnic‐Specific Differences in the Effects of Inhaled Corticosteroid Use on Bronchodilator Response in Patients With Asthma.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 1133, doi. 10.1002/cpt.1555
- By:
- Publication type:
- Article
An Analysis of Follow‐On Development in New Drug Classes, January 1986–June 2018.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 1125, doi. 10.1002/cpt.1554
- By:
- Publication type:
- Article
Prediction of the Impact of Cytochrome P450 2C9 Genotypes on the Drug–Drug Interaction Potential of Siponimod With Physiologically‐Based Pharmacokinetic Modeling: A Comprehensive Approach for Drug Label Recommendations.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 1113, doi. 10.1002/cpt.1547
- By:
- Publication type:
- Article
Enhancing the Visibility and Prestige of Clinical Pharmacology as a Medical Subspecialty.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 914, doi. 10.1002/cpt.1546
- By:
- Publication type:
- Article
Investigation on the Existence of Sex‐By‐Formulation Interaction in Bioequivalence Trials.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 1099, doi. 10.1002/cpt.1539
- By:
- Publication type:
- Article
Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real‐World Data.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 925, doi. 10.1002/cpt.1536
- By:
- Publication type:
- Article
Response to "Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real‐World Data".
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 927, doi. 10.1002/cpt.1533
- By:
- Publication type:
- Article
A Comprehensive Analysis of Ontogeny of Renal Drug Transporters: mRNA Analyses, Quantitative Proteomics, and Localization.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 1083, doi. 10.1002/cpt.1516
- By:
- Publication type:
- Article
The Effect of Using Pazopanib With Food vs. Fasted on Pharmacokinetics, Patient Safety, and Preference (DIET Study).
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 1076, doi. 10.1002/cpt.1515
- By:
- Publication type:
- Article
Clopidogrel Drug Interactions and Serious Bleeding: Generating Real‐World Evidence via Automated High‐Throughput Pharmacoepidemiologic Screening.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 1067, doi. 10.1002/cpt.1507
- By:
- Publication type:
- Article
Positron Emission Tomography Imaging of [<sup>11</sup>C]Rosuvastatin Hepatic Concentrations and Hepatobiliary Transport in Humans in the Absence and Presence of Cyclosporin A.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 1056, doi. 10.1002/cpt.1506
- By:
- Publication type:
- Article
Nivolumab Clearance Is Stationary in Patients With Resected Melanoma on Adjuvant Therapy: Implications of Disease Status on Time‐Varying Clearance.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 1018, doi. 10.1002/cpt.1502
- By:
- Publication type:
- Article
A Quantitative Justification of Similarity in Placebo Response Between Adults and Adolescents With Acute Exacerbation of Schizophrenia in Clinical Trials.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 1046, doi. 10.1002/cpt.1501
- By:
- Publication type:
- Article
Pharmacokinetic/Pharmacodynamic Modeling to Support the Re‐approval of Gemtuzumab Ozogamicin.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 1006, doi. 10.1002/cpt.1500
- By:
- Publication type:
- Article
Healthy User Bias in Comparative Safety Studies for Brand‐Name vs. Generic Products: The Example of Warfarin.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 1037, doi. 10.1002/cpt.1498
- By:
- Publication type:
- Article
Shared Genetic Risk Factors Across Carbamazepine‐Induced Hypersensitivity Reactions.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 1028, doi. 10.1002/cpt.1493
- By:
- Publication type:
- Article
Effectiveness of Antiplatelet Drugs Under Therapeutic Hypothermia: A Comprehensive Review.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 993, doi. 10.1002/cpt.1492
- By:
- Publication type:
- Article
An Old Drug for a New Indication: Repurposing Fenfluramine From an Anorexigen to an Antiepileptic Drug.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 929, doi. 10.1002/cpt.1469
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 893, doi. 10.1002/cpt.1160
- Publication type:
- Article
A Framework Proposal to Follow‐Up on Preclinical Convulsive Signals of a New Molecular Entity in First‐in‐Human Studies Using Electroencephalographic Monitoring.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 968, doi. 10.1002/cpt.1455
- By:
- Publication type:
- Article
Is Pharmacogenetics Useful in Antidepressant Treatment?
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 916, doi. 10.1002/cpt.1451
- By:
- Publication type:
- Article
Quantifying Preferences in Drug Benefit‐Risk Decisions.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 955, doi. 10.1002/cpt.1447
- By:
- Publication type:
- Article
Trials in "True" Dyslipidemic Patients Are Urged to Reconsider Comprehensive Lipid Management as a Means to Reduce Residual Cardiovascular Risk.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 960, doi. 10.1002/cpt.1436
- By:
- Publication type:
- Article
Model‐Based Meta‐Analysis: Optimizing Research, Development, and Utilization of Therapeutics Using the Totality of Evidence.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 981, doi. 10.1002/cpt.1462
- By:
- Publication type:
- Article